PHAXIAM Therapeutics S.A. Working Capital to Net Assets Ratio
PHAXIAM Therapeutics S.A. working capital to net assets ratio. PHAXIAM Therapeutics S.A. (PHXM) has a Working Capital to Net Assets ratio of -62.3% as of June 2024. Working capital of €-9.62 Million (current assets of €5.89 Million minus current liabilities of €15.51 Million) is measured against net assets of €15.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check PHAXIAM Therapeutics S.A. (PHXM) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of PHAXIAM Therapeutics S.A. (2012–2023)
Working capital to net assets ratio of PHAXIAM Therapeutics S.A. from 2012 to 2023. This chart shows how PHAXIAM Therapeutics S.A.'s Working Capital to Net Assets ratio has evolved across 12 annual periods from 2012 to 2023. As of June 2024, the ratio stands at -62.3%, reflecting working capital of €-9.62 Million against net assets of €15.45 Million EUR. See PHXM defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
PHAXIAM Therapeutics S.A. Working Capital to Net Assets Ratio by Year (2012–2023)
PHAXIAM Therapeutics S.A. working capital to net assets ratio by year from 2012 to 2023. The table below presents the year-by-year Working Capital to Net Assets ratio for PHAXIAM Therapeutics S.A. from 2012 to 2023, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of PHAXIAM Therapeutics S.A..
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 3.7% | €955.00K | €25.61 Million | €16.22 Million | €15.26 Million | ▼ -128.1 pp |
| 2022 | 131.8% | €30.96 Million | €23.49 Million | €42.63 Million | €11.68 Million | ▲ +44.1 pp |
| 2021 | 87.7% | €20.04 Million | €22.84 Million | €40.05 Million | €20.00 Million | ▲ +11.3 pp |
| 2020 | 76.4% | €20.29 Million | €26.54 Million | €49.63 Million | €29.35 Million | ▲ +4.3 pp |
| 2019 | 72.1% | €61.70 Million | €85.56 Million | €81.58 Million | €19.88 Million | ▼ -16.7 pp |
| 2018 | 88.8% | €129.26 Million | €145.60 Million | €149.91 Million | €20.65 Million | ▼ -10.4 pp |
| 2017 | 99.2% | €179.96 Million | €181.42 Million | €191.57 Million | €11.61 Million | ▼ -2.3 pp |
| 2016 | 101.5% | €36.19 Million | €35.64 Million | €42.53 Million | €6.35 Million | ▲ +3.3 pp |
| 2015 | 98.3% | €46.31 Million | €47.13 Million | €51.93 Million | €5.62 Million | ▼ -0.2 pp |
| 2014 | 98.4% | €35.27 Million | €35.82 Million | €39.53 Million | €4.26 Million | ▼ -1.1 pp |
| 2013 | 99.5% | €13.52 Million | €13.59 Million | €17.04 Million | €3.51 Million | ▲ +140.8 pp |
| 2012 | -41.3% | €1.66 Million | €-4.03 Million | €9.14 Million | €7.48 Million | — |